Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes

DOI: 10.3390/cancers10030062

Keywords: anaplastic large-cell lymphoma (ALCL), anaplastic lymphoma kinase (ALK), ALK inhibitors, non-small-cell lung cancer (NSCLC), resistance to ALK inhibitors, targeted therapies, tyrosine kinase (TK)

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text